- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 21, 2025 | 1.68B sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $23.43B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $23.4B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $4.73B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.13B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$3.51B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$2.24B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $10.66B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.78B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $39.22B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $37.37B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $6.08B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $4.51B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $35.76B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $35.18B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.76B sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $2.4B |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1.73B |
| Capex | Q1 2025 · Mar 31, 2024 | $35M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2.88B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.21 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.21 |
| Net Income | Q1 2025 · Mar 31, 2024 | $2.13B |
| Operating Income | Q1 2025 · Mar 31, 2024 | $2.67B |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $3.28B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $1.44B |
| Revenue | Q1 2025 · Mar 31, 2024 | $5.58B |